Penn Capital Management’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,249
Closed -$370K 191
2025
Q4
$370K Buy
+6,249
New +$339K 0.03% 159
2025
Q1
Sell
-46,771
Closed -$1.91M 180
2024
Q4
$1.91M Sell
46,771
-49,769
-52% -$2.07M 0.19% 99
2024
Q3
$3.77M Buy
96,540
+3,691
+4% +$147K 0.35% 87
2024
Q2
$4.06M Sell
92,849
-9,438
-9% -$456K 0.38% 85
2024
Q1
$4.88M Buy
102,287
+51,874
+103% +$2.33M 0.43% 77
2023
Q4
$2.38M Buy
50,413
+31,475
+166% +$1.31M 0.22% 94
2023
Q3
$917K Buy
18,938
+11,164
+144% +$609K 0.09% 121
2023
Q2
$452K Buy
+7,774
New +$466K 0.04% 137

Other funds holding NGVT

Penn Capital Management's NGVT Position: Q1 2026 in Review

Penn Capital Management sold out of Ingevity (NGVT) in Q1 2026, closing a stake of 6,249 shares — an estimated $370K sold.

Penn Capital Management first reported a position in NGVT in Q2 2023 and held it in 8 quarters. The position peaked at $4.88M in Q1 2024. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Penn Capital Management reported no remaining Ingevity position as of Q1 2026 after selling out during the quarter.
  • Penn Capital Management sold 6,249 Ingevity shares in Q1 2026, an estimated $370K.
  • Penn Capital Management first reported a position in Ingevity in Q2 2023 and held it in 8 quarters.
  • Penn Capital Management's Ingevity position peaked at $4.88M in Q1 2024.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Penn Capital Management's 13F filing for Q1 2026, filed 7 May 2026.